OIG March 2018 Report:
“Drug Supply Chain Security: Dispensers Received Most Tracing Information”
In March 2018, The Office of Inspector General (OIG) issued its second in a series of three anticipated examinations of drug supply chain security focusing on the implementation of the Drug Supply Chain Security Act (DSCSA). The report focuses on the survey results of 40 healthcare/retail pharmacy organizations:
- 20 independent/chain retail pharmacies and
- 20 small/large hospitals/health systems
The report focuses on two key DSCSA aspects:
- Availability/missing drug product tracing/transaction information
- Retail pharmacy/healthcare organizations awareness of DSCSA and requirements
Want to read the entire article?
Sign up now to view the document.
Excellis is committed to protecting your privacy and personal information. All information will be kept confidential.